Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$348,746,619
+$12,768,887 QoQ
Shares Held
5,777,777
0.0% QoQ
Ownership
5.97%
of shares outstanding
% of Portfolio
3.13%
of 13F equity value
Holder Rank
#3
of 314 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avoro Capital Advisors LLC holds $9,631,167,263 across 25 Biotechnology names. XENE ranks #11 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
5,111,111 | $1,363,235,525 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
2,888,888 | $1,073,713,002 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,833,333 | $984,408,154 | |
| 4 | ARGX |
Argenx SE
|
1,000,000 | $927,770,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
11,355,555 | $925,591,288 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
7,474,747 | $857,129,238 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,297,000 | $430,182,160 | |
| 8 | CYTK |
Cytokinetics Inc
|
4,999,999 | $425,949,914 |
All Filings in XENE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $348,746,619 | 5,777,777 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $335,977,732 | 5,777,777 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $243,123,580 | 5,424,444 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $216,810,000 | 5,400,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $169,020,000 | 5,400,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $192,632,894 | 5,741,666 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $222,133,307 | 5,666,666 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $223,096,640 | 5,666,666 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $220,943,307 | 5,666,666 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $243,949,971 | 5,666,666 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $261,006,635 | 5,666,666 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $167,384,000 | 4,900,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $188,650,000 | 4,900,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $175,371,000 | 4,900,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $193,207,000 | 4,900,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $176,890,000 | 4,900,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $149,058,000 | 4,900,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $152,391,450 | 4,985,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $155,731,400 | 4,985,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $55,772,000 | 3,650,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $67,963,000 | 3,650,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $65,335,000 | 3,650,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $43,064,000 | 2,800,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $30,996,000 | 2,800,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $35,112,000 | 2,800,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $31,434,480 | 2,772,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||